1. Home
  2. CINT vs DNA Comparison

CINT vs DNA Comparison

Compare CINT & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CI&T Inc

CINT

CI&T Inc

HOLD

Current Price

$5.00

Market Cap

566.6M

Sector

Technology

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$6.72

Market Cap

607.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CINT
DNA
Founded
1995
2008
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
566.6M
607.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CINT
DNA
Price
$5.00
$6.72
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$6.80
$10.50
AVG Volume (30 Days)
155.5K
978.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.00
N/A
Revenue Next Year
$12.62
$3.07
P/E Ratio
$17.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.98
$5.00
52 Week High
$7.28
$17.58

Technical Indicators

Market Signals
Indicator
CINT
DNA
Relative Strength Index (RSI) 54.96 34.04
Support Level $4.93 N/A
Resistance Level $5.24 $10.05
Average True Range (ATR) 0.19 0.71
MACD -0.01 -0.14
Stochastic Oscillator 72.41 0.81

Price Performance

Historical Comparison
CINT
DNA

About CINT CI&T Inc

CI&T Inc is engaged in providing plans, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: